Burden of Chronic obstructive pulmonary disease in China: an analysis based on the GBD 2021 compared with the United States

中国慢性阻塞性肺疾病负担:基于GBD 2021与美国对比分析

阅读:1

Abstract

BACKGROUND: Chronic obstructive pulmonary disease is an important disease affecting physical health worldwide, and the burden of this disease has been growing since 1991 for both China and the US. OBJECTIVE: To examine the changes in the burden of COPD in both China and the US between 1990-2021. METHODS: The joinpoint analysis, age-Period-Cohort analysis, decomposition analysis, predictive analysis methods were used to describe prevalence, incidence, death, and disability-adjusted life years for COPD in China and the US. RESULTS: Compared with China, all four measures of the US COPD burden were higher than they had been in 1990. The burden of COPD increases with age in China. Conversely, in the US, the burden of COPD is getting younger. The epidemiological changes have contributed to an increasing burden of COPD in the US, but have led to a decline in the burden of COPD in China. By 2042, the number of cases in both countries will rise, especially the death rate in the US. CONCLUSION: The burden of COPD will not rapidly decline in the short term, both China and the US, as well as the global community, must take this disease seriously.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。